Efficacy and safety of dabigatran in patients with atrial fibrillation scheduled for transoesophageal echocardiogram-guided direct electrical current cardioversion: a prospective propensity score-matched cohort study

NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world

(2017) Emanuele Bertaglia et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The clinical performance of dabigatran in the Italian real-life experience

(2017) Vincenzo Russo et al.   Journal of Cardiovascular Medicine

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience

(2016) Vincenzo Russo et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Is one month treatment with dabigatran before cardioversion of atrial fibrillation sufficient to prevent thromboembolism?: Table 1

(2015) Anna-Karin Johansson et al.   EUROPACE

Transesophageal echocardiograpy in patients with persistent atrial fibrillation undergoing electrical cardioversion on new oral anticoagulants: A multi center registry

(2015) Giuseppe Stabile et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin—A Nationwide Cohort Study

(2015) Jannik Langtved Pallisgaard et al.   PLoS One

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2014) Craig T. January et al.   CIRCULATION

Dabigatran Versus Warfarin in Patients With Atrial Fibrillation

(2011) Rangadham Nagarakanti et al.   CIRCULATION

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPEAN HEART JOURNAL

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

(2009) Timothy Watson et al.   LANCET

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE